Editorial: Pharma reluctant to serve Europe to get rid of MFN drug prices
Drug industry giants managed last year to allay some concerns about drug prices. Pharmacy Benefit Managerswhile publicly agreeing to lower some rates with the White House. These flashy announcements helped create the illusion that action was being taken to help Americans pay less for their prescription drugs, and the pharmaceutical industry received some improvement in … Read more